Mayne Pharma Group Limited
MAYNF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$68,291 | -$25,545 | -$103,681 | -$70,549 |
| Dep. & Amort. | $38,412 | $34,365 | $34,203 | $37,418 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,851 | $2,105 | $1,576 | $2,515 |
| Change in WC | $21,368 | $21,289 | $30,323 | -$19,821 |
| Other Non-Cash | $37,159 | -$45,244 | $51,000 | $21,716 |
| Operating Cash Flow | $30,499 | -$13,030 | $13,421 | -$25,194 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5,404 | -$6,872 | -$4,776 | -$16,194 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | -$4,720 | $91,628 |
| Other Inv. Act. | -$17,675 | -$38,122 | -$4,262 | -$8,227 |
| Investing Cash Flow | -$23,079 | -$44,994 | -$13,758 | $67,207 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$2,066 | $0 | -$1,806 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$148 | $0 | -$10,932 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$296 | $1,954 | $351 | -$16,456 |
| Financing Cash Flow | -$296 | -$260 | $351 | -$23,728 |
| Forex Effect | -$995 | $1,926 | $827 | -$1,674 |
| Net Chg. in Cash | -$53,710 | $53,710 | -$109,227 | $7,513 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $53,710 | $0 | $109,227 | $101,714 |
| End Cash | $0 | $53,710 | $112,388 | $109,227 |
| Free Cash Flow | $25,095 | -$19,902 | $8,645 | -$41,388 |